Mainz Biomed N.V.
MYNZ
$1.59
-$0.02-1.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 143.40K | 143.40K | 186.60K | 186.60K | 260.40K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 143.40K | 143.40K | 186.60K | 186.60K | 260.40K |
| Cost of Revenue | 48.60K | 48.60K | 58.70K | 58.70K | 100.90K |
| Gross Profit | 94.80K | 94.80K | 127.90K | 127.90K | 159.50K |
| SG&A Expenses | 2.61M | 2.61M | 3.14M | 3.14M | 3.44M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.19M | 4.19M | 4.49M | 4.49M | 5.16M |
| Operating Income | -4.05M | -4.05M | -4.31M | -4.31M | -4.90M |
| Income Before Tax | -4.17M | -4.17M | -5.31M | -5.31M | -5.51M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.17M | -4.17M | -5.31M | -5.31M | -5.51M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.17M | -4.17M | -5.31M | -5.31M | -5.51M |
| EBIT | -4.05M | -4.05M | -4.31M | -4.31M | -4.90M |
| EBITDA | -3.87M | -3.87M | -4.12M | -4.12M | -4.66M |
| EPS Basic | -1.33 | -1.33 | -3.86 | -3.86 | -9.86 |
| Normalized Basic EPS | -0.83 | -0.83 | -2.01 | -2.01 | -5.87 |
| EPS Diluted | -1.33 | -1.33 | -3.86 | -3.86 | -9.86 |
| Normalized Diluted EPS | -0.83 | -0.83 | -2.01 | -2.01 | -5.87 |
| Average Basic Shares Outstanding | 3.14M | 3.14M | 1.38M | 1.38M | 558.80K |
| Average Diluted Shares Outstanding | 3.14M | 3.14M | 1.38M | 1.38M | 558.80K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |